Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Tax Provisions (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Tax Provisions over the past 15 years, most recently at $33000.0 for Q2 2025.

  • For Q2 2025, Tax Provisions rose 157.89% year-over-year to $33000.0; the TTM value through May 2025 reached $43000.0, down 76.5%, while the annual FY2025 figure was $43000.0, 76.5% down from the prior year.
  • Tax Provisions for Q2 2025 was $33000.0 at Lifecore Biomedical, Inc. \De\, up from -$8000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $3.4 million in Q1 2022 and troughed at -$9.4 million in Q2 2021.
  • A 5-year average of -$825277.8 and a median of $4000.0 in 2022 define the central range for Tax Provisions.
  • On a YoY basis, Tax Provisions climbed as much as 2100.0% in 2023 and fell as far as 1725.0% in 2023.
  • Year by year, Tax Provisions stood at -$6.3 million in 2021, then skyrocketed by 100.06% to $4000.0 in 2022, then plummeted by 1725.0% to -$65000.0 in 2023, then skyrocketed by 166.15% to $43000.0 in 2024, then dropped by 23.26% to $33000.0 in 2025.
  • Business Quant data shows Tax Provisions for LFCR at $33000.0 in Q2 2025, -$8000.0 in Q1 2025, and $43000.0 in Q4 2024.